Answers are grounded in this paper and cite their sources.
Different NADPH-dependent oxidoreductases, namely AKR1A1, AKR1B10, AKR1C3, and CBR1, are responsible for daunorubicin metabolism and are thus involved in chemoresistance. Here, we used thiazolidinone derivatives as inhibitors of these enzymes in order to define daunorubicin detoxification in the lung carcinoma A549 cell line, in which the four enzymes are all expressed. The evaluation of the effect of different inhibitors on both daunorubicin transformation in cell extracts and daunorubicin toxicity in cultured cells supports a prominent contribution of CBR1 to daunorubicin reduction in A549 cells. A combined treatment of A549 cells with daunorubicin and the most promising compound among those tested induced both significant cytotoxicity, which occurred through an increase in the apoptotic rate, and a complete impairment of clonogenic survival. These results suggest CBR1 as a potential target to impair daunorubicin metabolism in A549 cells.
No takes yet. Share an insight, caveat, or question.
Sardelli et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: